However, Torrent Pharma was hurt due to the closure of an insulin manufacturing facility in August and a 17% on-year depreciation in Brazil's currency, the company said.

India's Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure January ... beating analysts' estimates and valuing the company at 18.64 billion rupees ($223.3 million), as ...

(Reuters) - India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company ...